Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academics Conferences

“Advanced Therapeutic and Modern Oncological Technologies”
- preventiveoncology 2017


Las Vegas is largest city of Nevada. Its population is around 600,000.Las Vegas is the 29th-most populated city in the United States, the most populated city in the state of Nevada, and the county seat of Clark County. The city anchors the Las Vegas Valley metropolitan area and is the largest city within the greater Mojave Desert. It is the leading financial, commercial, and cultural center for Nevada. Las Vegas is having oncology department in many universities.

Welcome Message

Allied Academies welcomes you all with a great pleasure and honor to extend a warm invitation to attend the “World Congress on Preventive Oncology", held during October 05-06, 2017, in Las Vegas, Nevada, USA

The Main theme of the conference is “Advanced Therapeutic and Modern Oncological Technologies”.

Preventive Oncology 2017 will be a great platform for research scientists and young researchers to share their current findings in the field of applied sciences.

Market Analysis


Introduction & Scope


The Las Vegas Valley is a major metropolitan area located in the southern part of the U.S.A state of Nevada. It’s a warm region, having temperature ranges between 26 to 28 degree centregrade. Now-a-days cancer cases are becoming more in USA. Around one third of cancer deaths are due to the five leading behavioral and dietary risks: high body mass index, low fruit and vegetable intake, lack of physical activity, tobacco use, alcohol use, and one half of all cancer cases either arise from modifiable risk factors or can be detected as precursor lesions before the development of disease with metastatic potential.

Preventive Oncology welcomes attendees, presenters and exhibitors from all over the world to Las Vegas, Nevada. We are delighted to invite you all to attend and register for the “World Congress Preventive Oncology” which is going to be held during October 5-6, 2017 at Las Vegas, Nevada.

Study Goals and Objectives:

The organizing committee is going to organize an exciting and informative conference program including plenary lectures, symposia, workshops on a variety of topics, poster presentations and various programs for participants from all over the world. We invite you to join us at Las Vegas, Nevada on October 5-6, 2017 where you will be sure to have a meaningful experience with scholars from around the world. All the members of World Congress Preventive Oncology organizing committee look forward to meet you at Las Vegas, Nevada.

 Why Las Vegas?

Las Vegas is largest city of Nevada. Its population is around 600,000.Las Vegas is the 29th-most populated city in the United States, the most populated city in the state of Nevada, and the county seat of Clark County. The city anchors the Las Vegas Valley metropolitan area and is the largest city within the greater Mojave Desert. It is the leading financial, commercial, and cultural center for Nevada. Las Vegas is having oncology department in many universities.

Cancer Association in USA
Cancer Association Of America
American Association for Cancer Research
American Breast Cancer Foundation
Kidney Cancer Association
American Breast Cancer Foundation
National Breast Cancer Foundation
American Society of Clinical Oncology
The Skin Cancer Foundation
Oncology Universities in USA

Stanford University

Duke University

Northwestern University Feinberg School of Medicine

Wash U School of Medicine in St. Louis and many more universities

Intended Audience:


Clinical professionals

Research scholars of cancer

Pharmacy professionals

Pharmaceuticals companies

Nutritionists and Dieticians

Public health departments

Market Scenario

An overview of the global markets and technologies for biological therapies for cancer. Analyses of global market trends, with data from 2013 and 2014, and projections of compound annual growth rates (CAGRs) through 2019. Details concerning the strengths, weaknesses, opportunities, and threats facing various cancer biotherapeutics already on the market.

The global market for the prevention and treatment of prostate cancer was valued at $26.1 billion in 2011 and should reach nearly $29.3 billion in 2012. Total market value is expected to reach $50.3 billion in 2017 after increasing at a five-year compound annual growth rate (CAGR) of 11.4%.

 The global gastric cancer diagnostic/screening and treatment market was $235.5 billion in 2014. This market is expected to grow from $241.7 billion in 2015 to nearly $318.3 billion by 2020, with a compound annual growth rate (CAGR) of 5.7%.

The global market for cancer vaccines was about $4.5 billion in 2013. This market reached about $4.0 billion in 2014 and is expected to reach $4.3 billion in 2019, registering a compound annual growth rate (CAGR) of 1.3% for the period 2014-2019.

 The market and sales data for various years gives strong support for the research and development (R&D) program and the move toward biologic treatment for cancer, as well as within biologic toward human monoclonal antibodies, vaccines and interferons. The biologic drug classes discussed in this report with special focus on cancer treatment are:

Monoclonal antibodies
Colony stimulating factors
Interleukins and interferons

Coverage of the cancer vaccines arena including diverse therapeutic platform technologies, immune-stimulating agents and approved vaccines for cancer. An overview of the current and potential global market for cancer immunotherapy and virology. It presents analyses of global market trends, with data from 2012 and 2013, and projections of CAGRs through 2018.The study also includes comprehensive information on a number of the most common cancers, highlighting global incidence and prevalence. 


The information developed in this report is intended only for the purpose of understanding the scope of hosting related international meetings at the respective locations. This information does not constitute managerial, legal or accounting advice, nor should it be considered as a corporate policy guide, laboratory manual or an endorsement of any product, as much of the information is speculative in nature. Conference Organizers take no responsibility for any loss or damage that might result from reliance on the reported information or from its use.


01: Preventive Oncology:

Preventive oncology is any measure that is taken to prevent development or progression of malignant process. Around one third of cancer deaths are due to the five leading behavioral and dietary risks: high body mass index, low fruit and vegetable intake, lack of physical activity, tobacco use, alcohol use, and one half of all cancer cases either arise from modifiable risk factors or can be detected as precursor lesions before the development of disease with metastatic potential.

Prevention of cancer can take place on several different levels: primary prevention addresses the cause of cancer so disease does not occur, secondary prevention identifies disease before the onset of symptoms and keeps it from becoming more extensive, and tertiary prevention reduces complications and progression of disease once it has become clinically apparent.

  • Gene therapy may help prevent cancer metastasis
  • Blood sample new way of detecting cancer
  • Breakthrough: Using skin cells to kill cancer
  • T-Cell Therapy gives hope for advanced lymphoma

02: Molecular Oncology:

Molecular Oncology refers to the investigation of the chemistry of cancer and tumors at the molecular scale. The examination of the science of malignancy and tumors at the sub-atomic scale. Additionally the advancement and use of molecularly focused on treatments. In atomic oncology the distinguish qualities are included in the improvement of disease. 

  • Molecular Diagnosis
  • Pre malignant lesions
  • Cancer genetics
  • Integrating tumor microenvironment
  • Cancer immunotherapy

03: Cancer Cell Metabolism:

Tumor cells metabolize glucose, lactate, pyruvate, hydroxybutyrate, acetate, glutamine and fatty acids at much higher rates than their non-tumor equivalents; however, the metabolic ecology of tumors is composite because they contain multiple metabolic compartments, which are linked by the transfer of these catabolites. This metabolic changeability and flexibility enables tumor cells to generate ATP as an energy source, while maintaining the reduction–oxidation (redox) balance and committing resources to biosynthesis processes that are essential for cell survival, growth and proliferation.

  • Metabolic immuno –oncology
  • Molecular-Genetic Imaging 
  • Preclinical and clinical studies of metabolism-related cancer therapies

04: Oral and Oropharyngeal Cancer:

Oral cavity cancers the tumor is growing into an area called the masticator space and Oropharyngeal cancers the tumor is growing into a muscle called the lateral pterygoid muscle. And the tumor is growing into the nasopharynx (the area of the throat that is behind the nose).

  • Indirect pharyngoscopy and laryngoscopy diagnostic procedures
  • Direct (flexible) pharyngoscopy and laryngoscopy
  • Panendoscopy

5: Anti-Cancer Drugs:

Anticancer drugs are used to control the growth of cancerous cells. Cancer is commonly defined as the uncontrolledgrowth of cells, with loss of differentiation and commonly, with metastasis, spread of the cancer to other tissues and organs. Anticancer medications are utilized when the tumor has spread, or may spread, to all regions of the body.

  • Drug Discovery
  • Pharmacokinetics
  • Pharmacology
  • Adverse effects
  • Chemotherapy
  • Nanotechnology in cancer drugs

06: Cancer Immunoprevention:

Cancer immune prevention is the prevention of cancer onset with immunological means such as vaccines, immuno-stimulators or antibodies. Most tumor-associated antigens (TAA) are self-molecules that are abnormally expressed in cancer cells and become targets of antitumor immune responses. Antibodies and T cells specific for some TAAs have been found in healthy individuals and are associated with lowered lifetime risk for developing cancer. Lower risk for cancer has also been associated with a history of febrile viral diseases. A CIP study identified new antibodies against tumor cell proteins that were elicited by influenza infection. Cancer vaccines based on human tumor-associated antigens (TAA) have been tested in patients with advanced or recurrent cancer, in combination with or following standard therapy.

  • Immuno Prevention of Tumors Caused by Viruses
  • Immuno Prevention of non-infectious tumor
  • Cancer Immune Editing
  • Immune Response

07: Cancer Epidemiology:

Cancer epidemiology is the study of the distribution and determinants of the likelihood of cancer development. Cancer epidemiology can be used to identify events that increase or decrease cancer occurrence in specific people cancer epidemiology uses epidemiological methods to find the cause of cancer and to identify and develop improved treatments. Normally Squamous cell carcinoma of the lung is a central rather than a peripheral form of lung cancer. Rates of squamous cell carcinoma in the lung periphery are typically sited in the 15-30% range.  Given the differences in cell biology and carcinogenesis of central versus peripheral SCC, a potential epidemiologic shift might suggest a change in tumor biology.

  • Hepatocellular carcinoma 
  • Squamous cell carcinoma epidemiology
  • Prostate cancer

08: Gynecologic Oncology:

A Gynecologic oncology is study of which specializes in the diagnosis and treatment of women with cancer of the reproductive organs Including ovarian cancer, uterine cancer, vaginal cancer, cervical cancer, and vulvar cancer. The primary treatment for ovarian cancer, followed in most patients by systemic chemotherapy. By the Aggressive exploitation of operative laparoscopy, even only for selected patients, into the surgical practice of a gynecologic oncology service demonstrates significant improvements in LOS (laparoscopy on length of stay) without adversely affecting surgical complication rates based on different types of cancers.

  • Cervical cancer
  • Endometrial/uterine cancer
  • Gestational trophoblastic disease
  • Ovarian cancer- including fallopian tube, peritoneal, germ cell, and stromal cell
  • Vaginal cancer
  • Vulvar cancer

09: Stem Cells Therapy: 

Stem-cell therapy is the use of stem cells to treat or prevent a disease or condition. In a typical stem cell transplant for cancer very high doses of chemo are used, sometimes along with radiation therapy, to try to kill all the cancer cells. This treatment also kills the stem cells in the bone marrow. Soon after treatment, stem cells are given to replace those that were destroyed. These stem cells are given into a vein, much like a blood transfusion. Over time they settle in the bone marrow and begin to grow and make healthy blood cells. This process is called engraftment.

  • Autologous stem cell transplants
  • Tandem transplants
  • Allogeneic stem cell transplants
  • Mini-transplants
  • Syngeneic stem cell transplants
  • Half-matched transplants

10: Medical & Surgical Cancer:

Surgery is the removal of the tumor and surrounding tissue during an operation. A doctor who specializes in treating cancer using surgery is called a surgical oncologist. Surgery is the oldest type of cancer therapy and remains an effective treatment for many types of cancer today. For most types of cancer, a biopsy is the only way to make a definitive diagnosis. During a surgical biopsy, the surgeon makes a cut called an incision in the skin. Then, he or she removes some or all of the suspicious tissue. Tumor removal, also called curative or primary surgery. Surgery is most commonly used to remove the tumor and some of the surrounding healthy tissue. The tissue surrounding the tumor is called the margin.

  • Cryosurgery
  • Reconstructive surgery
  • Hyperthermia
  • Lung cancer surgery
  • Photodynamic Therapy

11: Cancer Cell Biology:

The cell is the fundamental unit of life. It is the smallest structure of the body capable of performing all of the processes that define life. Each of the organs in the body, such as the lung, breast, colon, and brain, consists of specialized cells that carry out the organ's functions such as the transportation of oxygen, digestion of nutrients, excretion of waste materials, locomotion, reproduction, thinking, etc. here are two general sorts of quality transformations. One write, prevailing change, is brought about by a variation from the norm in one quality in a couple. The second broad kind of transformation, latent change, is described by both qualities in the pair being harmed.

  • Cancer biology
  • Cell cycle
  • Risk factors
  • Cancer genetics
  • Nanotechnology in Cancer

12: Radiation Oncology:

Radiation therapy occurs in the presence of biochemical recurrence after prostatectomy to assess whether this results in shifts of Histopathological prognostic factors such as the Gleason Score. By using ionizing radiation (such as megavoltage X-rays or radionuclides) in the treatment of cancer. The field of radiation oncology covers the integration of radiation therapy into multimodal treatment approaches. Radiation Oncology provides an open access forum for researchers and clinicians involved in the management and treatment of cancer patients, bringing together the latest research and advances in the field. Advances in treatment technology, as well as improved understanding of the underlying biological resistance mechanisms.

  • Radiation therapy
  • Stereotactic body radiation therapy (SBRT)
  • Intensity Modulated Radiotherapy (IMRT)
  • Intravascular Brachytherapy
  • Prostate Seed Implant

13.Cellular Reprograming:

It is provides for bits of learning on the etiology, change, and potential treatment of various ailments through reproducing cell instruments. Cell reconstructing is the way toward guiding full grown cells to a primitive condition of quality expression. The etiology and pathogenesis of SLE have not been completely seen. Innate, biological and viral maladies and diverse components might be related to the pathogenetic parts of Systemic lupus erythematosus. Interleukin-2 (IL-2) is a fundamental cytokine conveyed by T cells upon order and is basic for the time of T authoritative cells and incitation induced cell destruction. In SLE patients, T cells indicate reduced capacity to convey IL-2. Handicapped IL-2 expression realized lessened period of authoritative T lymphocytes, and deformation of activation affected cell passing.

  • Physiological cellular reprogramming

14.Hormone Replacement Therapy:

Treating menopausal symptoms with estrogen and progestin together is known as estrogen-progestin therapy or combined hormone therapy.   Hormonal replacement therapy (HRT) has a higher risk of being diagnosed with breast cancer. Before the link between HRT use and breast cancer risk was established, many postmenopausal women took HRT for many years to ease menopausal symptoms (hot flashes, fatigue) and to reduce bone loss. Since 2002, when research linked HRT and risk, the number of women taking HRT has dropped dramatically. Still, many women continue to use HRT to handle bothersome menopausal symptoms.

  • postmenopausal hormone therapy
  • Estrogen replacement therapy
  • Menopausal hormone therapy
  • Breast soreness
  • Cyclic hormone therapy

15. Clinical Oncology:

Oncology is a branch of medicine that deals with the prevention, diagnosis and treatment of cancer. The three components which have improved survival in cancer are Prevention -This is by reduction of risk factors like tobacco and alcohol consumption. Early diagnosis-Screening of common cancers and comprehensive diagnosis and staging. Treatment - Multimodality management by discussion in tumor board and treatment in a comprehensive cancer center.

  • Screening
  • diagnosis and staging
  • Treatment
  • solid tumors
  • Risk factors
  • Lymphoma

16. Surgical Prevention of Cancer:

 Surgery is not considered an appropriate cancer prevention option for women who are not at the highest risk of breast cancer. There have been many recent advances in cancer prevention, including improved understanding of cancer biology, better characterization of premalignant disease, significant advances in cancer surveillance, and identification of effective chemoprevention regimens.  The issues governing decision making for surgical prevention vary widely among different cancer types, and include consideration of the age and level of cancer risk of the individual, the effectiveness of cancer surveillance for the particular organ at risk, the aggressiveness of the cancer once present, and the morbidity of surgery.

  • lymphocele prevention
  • surgical oncology
  • Prolonged thrombo prophylaxis
  • Urological surgery
  • Esophageal cancer surgery

17. Immuno Oncology:

Immuno-oncology therapies are medicines that use the body’s immune system to fight cancer. Immuno-oncology therapiesa activate our immune system, making it able to recognise cancer cells and destroy them Immune oncology refers to immune system. It is a collection of organs, cells and special molecules that helps protect you from infections, cancer and other diseases. When a different (foreign) organism enters into the body, for example a bacterium, the immune system recognizes it and then attacks it, preventing it from causing harm. This process is called an immune response. Immuno-oncology therapies were found that provide lasting anti-cancer benefits to patients who previously had very few treatment options available to them. Several immuno-oncology therapies are in the process of being approved for use by patients in Europe, for the treatment of advanced melanoma, lung cancer, colorectal, renal, prostate cancer and many other cancers.

  • Tumor microenvironment
  • Tumor immunology
  • Immuno-resistive drugs
  • Antitumor
  • Cell and gene therapy

18. Cancer Bioinformatics:

It is another interdisciplinary region including organic, measurable and computational sciences. Now a days bioinformatics innovation is for the most part utilized for the special growth investigation. Ribosomal S6 protein kinase 4 (RSK4) is a vital novel tumor silencer that hinders bosom disease cell development and initiates senescence. Utilizing pair proclivity cleaning, we got protein buildings that associated with RSK4 or RSK4m. Mass range examination was performed to distinguish the acquired protein edifices, and bioinformatics investigation was performed.

  • Cancer bioinformatics
  • Transltional bioinformatics
  • Bioinformatics gene
  • Bioinformatics drug
  • Biology bioinformatics

19: Oncology Nursing:

An oncology nurse is a nursing professional who specializes in caring for people with cancer. Oncology nurses often serve as your first line of communication, and help coordinate the many aspects of your care throughout cancer treatment.

  • Oncology nursing practice
  • Primary duties
  • Patient care
  • Oncology nursing and cancer care
  • Oncology nursing in USA

20: Advancements in Preventive Oncology:

Researchers are growing new treatments that objective specific sorts of tumor cells and limit their development. All alone or in blend with other option medications, these treatments can diminish the extent of tumors and manifestations. Some imaginative treatments give seek after individuals with malignancies that have been impervious to more medicines. 

  • Role of  Nano technology in cancer
  • Standard training on disease anticipation
  • Cancer epidemiology

21: Cancer Genetics:

Cancer is a genetic disease that is, cancer is caused by certain changes to genes that control the way our cells function, especially how they grow and divide. These changes include mutations in the DNA that makes up our genes Genetic changes that increase cancer risk can be inherited from our parents if the changes are present in germ cells, which are the reproductive cells of the body (eggs and sperm). In general, cancer cells have more genetic changes than normal cells. But each person’s cancer has a unique combination of genetic alterations. Some of these changes may be the result of cancer, rather than the cause. As the cancer continues to grow, additional changes will occur. Even within the same tumor, cancer cells may have different genetic changes.

  • Clinical DNA sequencing
  • Genetic testing on hereditary
  • Childhood cancer genomics
  • Retinoblastoma
  • Genetics of cancer

To Collaborate Scientific Professionals around the World

Conference Date October 5-6, 2017
Speaker Oppurtunity
Poster Oppurtunity Available
e-Poster Oppurtunity Available

Zeny Tebbens / Sales Group

Coordinator phone: 702-948-8130

Leah Harrison (Director of Sales) 702 508 8100


Join The Discussion

Contact Desk

Drop us an email for Program enquiry.

Jessie Casper

Sponsors / Exhibiting / Advertising.

Jessie Casper

General Queries

Jessie Casper

Special Issues
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by

Mail us at

Drop us an email for Program enquiry.
Sponsors / Exhibiting / Advertising.
General Queries
Copyright © 2017-2018 Allied Academies, All Rights Reserved.